Related references
Note: Only part of the references are listed.Intracellular prodrug gene therapy for cancer mediated by tumor cell suicide gene exosomes
Ursula Altanerova et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Genetically-engineered anti-PSMA exosome mimetics targeting advanced prostate cancer in vitro and in vivo
Maja Severic et al.
JOURNAL OF CONTROLLED RELEASE (2021)
A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile
Srikanth Boinapally et al.
SCIENTIFIC REPORTS (2021)
Genetically Engineered Cell-Derived Nanoparticles for Targeted Breast Cancer Immunotherapy
Xiaojing Shi et al.
MOLECULAR THERAPY (2020)
Biomimetic nanovesicles made from iPS cell-derived mesenchymal stem cells for targeted therapy of triple-negative breast cancer
Qingguo Zhao et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
An exosome-like programmable-bioactivating paclitaxel prodrug nanoplatform for enhanced breast cancer metastasis inhibition
Kaiyuan Wang et al.
BIOMATERIALS (2020)
Cancer therapy based on extracellular vesicles as drug delivery vehicles
Laura Cabeza et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Intracellular Activation of a Prostate Specific Antigen-Cleavable Doxorubicin Prodrug: A Key Feature Toward Prodrug-Nanomedicine Design
Sara G. T. Pereira et al.
MOLECULAR PHARMACEUTICS (2019)
Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery
Sagar Rayamajhi et al.
ACTA BIOMATERIALIA (2019)
Actively targeted nanocarriers for drug delivery to cancer cells
Stefania Biffi et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10
Kyong-Su Park et al.
STEM CELL RESEARCH & THERAPY (2019)
Cancer-derived exosomes loaded with ultrathin palladium nanosheets for targeted bioorthogonal catalysis
Maria Sancho-Albero et al.
NATURE CATALYSIS (2019)
Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy
Tuying Yong et al.
NATURE COMMUNICATIONS (2019)
Biofabrication of Cell-Derived Nanovesicles: A Potential Alternative to Extracellular Vesicles for Regenerative Medicine
Nazma F. Ilahibaks et al.
CELLS (2019)
Artificial chimeric exosomes for anti-phagocytosis and targeted cancer therapy
Kai-Long Zhang et al.
CHEMICAL SCIENCE (2019)
Membrane Radiolabelling of Exosomes for Comparative Biodistribution Analysis in Immunocompetent and Immunodeficient Mice - A Novel and Universal Approach
Farid N. Faruqu et al.
THERANOSTICS (2019)
Modification of Extracellular Vesicles by Fusion with Liposomes for the Design of Personalized Biogenic Drug Delivery Systems
Max Piffoux et al.
ACS NANO (2018)
The expanding role of prodrugs in contemporary drug design and development
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae?
Kulmira Nurgali et al.
FRONTIERS IN PHARMACOLOGY (2018)
Exosome-Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs
Yao Lin et al.
ADVANCED SCIENCE (2018)
nCVTs: a hybrid smart tumour targeting platform
Wei Jiang Goh et al.
NANOSCALE (2018)
A reliable murine model of bone metastasis by injecting cancer cells through caudal arteries
Takahiro Kuchimaru et al.
NATURE COMMUNICATIONS (2018)
Aptamer-Conjugated Extracellular Nanovesicles for Targeted Drug Delivery
Yuan Wan et al.
CANCER RESEARCH (2018)
EXOPLEXs: Chimeric Drug Delivery Platform from the Fusion of Cell-Derived Nanovesicles and Liposomes
Wei Jiang Goh et al.
BIOMACROMOLECULES (2018)
Cell type-specific and common characteristics of exosomes derived from mouse cell lines: Yield, physicochemical properties, and pharmacokinetics
Chonlada Charoenviriyakul et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Doxorubicin-loaded cell-derived nanovesicles: an alternative targeted approach for anti-tumor therapy
Wei Jiang Goh et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Dually folate/CD44 receptor-targeted self-assembled hyaluronic acid nanoparticles for dual-drug delivery and combination cancer therapy
Liang Song et al.
JOURNAL OF MATERIALS CHEMISTRY B (2017)
Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: a Cost-Effective Alternative
Wei Jiang Goh et al.
SCIENTIFIC REPORTS (2017)
Efficient production and enhanced tumor delivery of engineered extracellular vesicles
Dionysios C. Watson et al.
BIOMATERIALS (2016)
Discovery of PSMA-specific peptide ligands for targeted drug delivery
Wei Jin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2016)
The impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug delivery
Claudia Corbo et al.
NANOMEDICINE (2016)
Engineering hybrid exosomes by membrane fusion with liposomes
Yuko T. Sato et al.
SCIENTIFIC REPORTS (2016)
Effective internalization of U251-MG-secreted exosomes into cancer cells and characterization of their lipid components
Yuki Toda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Biodistribution and delivery efficiency of unmodified tumor-derived exosomes
Tyson Smyth et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Targeted Prodrug Approaches for Hormone Refractory Prostate Cancer
Herve Aloysius et al.
MEDICINAL RESEARCH REVIEWS (2015)
Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting
Oscar P. B. Wiklander et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Examination of the specificity of tumor cell derived exosomes with tumor cells in vitro
Tyson J. Smyth et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers
Wonju Jo et al.
LAB ON A CHIP (2014)
Bioinspired Exosome-Mimetic Nanovesicles for Targeted Delivery of Chemotherapeutics to Malignant Tumors
Su Chul Jang et al.
ACS NANO (2013)
Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer
Wenjin Xu et al.
BIOMATERIALS (2013)
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Shin-ichiro Ohno et al.
MOLECULAR THERAPY (2013)
Evaluation of Phage Display Discovered Peptides as Ligands for Prostate-Specific Membrane Antigen (PSMA)
Duanwen Shen et al.
PLOS ONE (2013)
Synthesis and Characterization of a Novel Prostate Cancer-Targeted Phosphatidylinositol-3-kinase Inhibitor Prodrug
Daniele Baiz et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Prodrug Strategy for PSMA-Targeted Delivery of TGX-221 to Prostate Cancer Cells
Yunqi Zhao et al.
MOLECULAR PHARMACEUTICS (2012)
Exosomes Released by Melanoma Cells Prepare Sentinel Lymph Nodes for Tumor Metastasis
Joshua L. Hood et al.
CANCER RESEARCH (2011)
Prostate Cancer Overview
Mary Weinstein Dunn et al.
Seminars in Oncology Nursing (2011)
Prostate-specific antigen: an overlooked candidate for the targeted treatment and selective imaging of prostate cancer
Aaron M. LeBeau et al.
BIOLOGICAL CHEMISTRY (2010)
Extracellularly Activated Nanocarriers: A New Paradigm of Tumor Targeted Drug Delivery
Emily Gullotti et al.
MOLECULAR PHARMACEUTICS (2009)
A dimeric peptide that binds selectively to prostate-specific membrane antigen and inhibits its enzymatic activity
Saurabh Aggarwal et al.
CANCER RESEARCH (2006)
Side-effects of treatments for locally advanced prostate cancer
KM O'Connor et al.
BJU INTERNATIONAL (2006)
In vitro targeting of synthesized anti body-conjugated dendrimer nanoparticles
TP Thomas et al.
BIOMACROMOLECULES (2004)
Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer
SR Denmeade et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells
A Kollara et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2003)
Design and synthesis of a pro-drug of vinblastine targeted at treatment of prostate cancer with enhanced efficacy and reduced systemic toxicity
SF Brady et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
The synthesis of a prodrug of doxorubicin designed to provide reduced systemic toxicity and greater target efficacy
VM Garsky et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
A peptide-doxorubicin 'prodrug' activated by prostate-specific antigen selectively kills prostate tumor cells positive for prostate-specific antigen in vivo
D DeFeo-Jones et al.
NATURE MEDICINE (2000)
Share Paper
